CAMLG (P49069) curation notes
Identity
- HGNC: CAMLG; aka CAML (calcium-modulating cyclophilin ligand), GET2.
- UniProt RecName: "Guided entry of tail-anchored proteins factor CAMLG".
- Multi-pass ER membrane protein: large cytoplasmic N-terminal region (1-189, disordered N-terminus), then three C-terminal TM helices (190-207, 213-231, 270-288). Topology established in PMID:31417168.
- Disease: Congenital disorder of glycosylation 2Z (CDG2Z, MIM:620201), autosomal recessive, neurological phenotype; caused by defective membrane trafficking (PMID:35262690 — not cached).
Core function: GET/TRC insertase receptor for tail-anchored (TA) proteins
CAML, together with WRB/GET1, forms the mammalian ER membrane receptor for the cytosolic ATPase TRC40/GET3, which delivers newly synthesized tail-anchored membrane proteins for post-translational insertion into the ER membrane. CAML is the mammal-specific subunit (not homologous to yeast Get2); WRB is the Get1 orthologue.
Reactome: R-HSA-9609523 "Insertion of tail-anchored proteins into the endoplasmic reticulum membrane".
GET complex membership and reciprocal stability with WRB
CAML and WRB depend on each other for stability/correct topology.
- PMID:32187542
- PMID:31417168
- GO terms: GET complex (GO:0043529) part_of — well supported (IDA PMID:32910895, IPI PMID:23041287). Protein stabilization (GO:0050821) is supported in the WRB/CAML context (PMID:32187542) but note PMID:20553626 also annotated stabilization in the unrelated RNF122 context.
Secondary / historical functions
Calcium signaling (original discovery)
CAML was originally cloned as a cyclophilin-B-binding protein that induces calcium influx in T cells and activates NF-AT/IL-2 transcription. This is the historical basis of the "defense response" (GO:0006952) and "signal transduction" (GO:0007165) TAS annotations from PMID:7522304. Plausible but largely supplanted by the well-established GET insertase role; treat as non-core/contextual.
- PMID:7522304
B cell homeostasis
By-similarity/ISS: "Essential for the survival of peripheral follicular B cells" (UniProt). Mouse phenotype; CAML interacts with TACI/TNFRSF13B (PMID:9311921 — not cached). Non-core for the human gene's molecular function.
EGFR recycling
CAML-deficient cells have defective EGFR recycling; CAML associates with the EGFR kinase domain ligand-dependently (PMID:12919676). This is the basis of Ensembl IEA "receptor recycling" and "epidermal growth factor receptor signaling pathway" terms (not in the current existing_annotations list except via interactome IPI). Context-dependent; potentially confounded by the general role of CAML in membrane protein biogenesis.
The negative regulation of (protein) ubiquitination / proteasomal catabolism / protein stabilization and ubiquitin-protein-ligase-binding annotations all derive from one yeast-two-hybrid + co-IP study of the RING E3 RNF122, in which CAML stabilizes RNF122 (and is not its substrate). These are narrow, single-study, context-specific findings, not the core GET function.
- PMID:20553626
- PMID:20553626
- GO:0005515 protein binding (IPI) appears ~12 times from interactome/Y2H/MaMTH/coronavirus-host studies (PMID:15451437, 16243292, 22046132, 24658140, 25416956, 28514442, 31980649, 32296183, 33961781, 40205054, 31417168, 32187542). Bare "protein binding" is uninformative; meaningful interactions (WRB, GET3, TACI, RNF122, EGFR) are captured by specific terms or noted in core function.
- GO:0016020 membrane (HDA, PMID:19946888) — generic; subsumed by ER membrane terms.
- GO:0005737 cytoplasm (IDA, PMID:20553626) — CAML has a large cytoplasmic domain, but the protein is an integral ER membrane protein; ER membrane terms are the correct localization.
Localization
Well supported: ER membrane / ER (multiple EXP/IDA: PMID:23041287, PMID:31417168, PMID:12919676). Core.
Summary of action plan
- CORE: GET complex (GO:0043529) part_of; tail-anchored membrane protein insertion into ER membrane (GO:0071816); protein insertion into ER membrane (GO:0045048); ER membrane (GO:0005789); endoplasmic reticulum (GO:0005783).
- NON-CORE (real but secondary/contextual): protein stabilization (GO:0050821, WRB/CAML context); B cell homeostasis (GO:0001782); defense response (GO:0006952); signal transduction (GO:0007165).
- NON-CORE single-study (RNF122): negative regulation of protein ubiquitination (GO:0031397), negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435), ubiquitin protein ligase binding (GO:0031625).
- OVER-ANNOTATED: bare protein binding (all IPI), generic membrane, cytoplasm.
Falcon deep research synthesis (2026-06-21)
Falcon deep research has now completed (file:human/CAMLG/CAMLG-deep-research-falcon.md,
25 citations). It strongly corroborates the GET/TRC insertase-receptor core above and
adds substrate-specificity and disease-mechanism detail; no change to the core call.
- Core confirmed. CAMLG (with WRB) is the ER receptor for TRC40/GET3 that
inserts tail-anchored (type-IV, C-terminal single-TMD) proteins post-
translationally; substrate selectivity is for relatively long, hydrophobic
C-terminal TMDs (less-hydrophobic TA proteins default to the EMC pathway).
Supports the GET-complex (GO:0043529) and TA-insertion calls.
- Specific TA-protein clients (Wilson 2022; Tirincsi 2022; Jung 2023). The
client spectrum is enriched for trafficking SNAREs — STX5, BET1L, SEC22B,
VAMP7, VTI1A (itself a PROTEOSTASIS gene in this batch), STX6, VAPA/VAPB —
plus Sec61β/γ and nuclear-membrane TA proteins (emerin/EMD, CUX1). Useful
has-input/affected-client context for the insertase function.
- CDG2Z mechanism made concrete. CAMLG-CDG (congenital disorder of
glycosylation) arises because loss of TA insertion mislocalizes Golgi SNAREs,
especially STX5 and BET1L (membrane→cytosol), disrupting Golgi trafficking and
causing combined N-/O-glycosylation defects (Wilson 2022). This is the
mechanistic basis for the CDG2Z disease noted above — links the ER insertase MF
to the downstream glycosylation phenotype.
- Quality-control interplay. CAMLG/TRC works with SGTA and the BAG6
complex, which route TA proteins between productive insertion and
ubiquitin-mediated degradation (Farkas 2021) — supports the proteostasis (PN)
framing and the protein-stabilization context.
Net: no change to calls — CAMLG is the mammal-specific ER GET-pathway insertase
receptor subunit (with WRB) for tail-anchored proteins; the new client/disease
detail strengthens that core and its proteostasis relevance.